167 related articles for article (PubMed ID: 16186628)
21. Aging and regulated protein degradation: who has the UPPer hand?
Vernace VA; Schmidt-Glenewinkel T; Figueiredo-Pereira ME
Aging Cell; 2007 Oct; 6(5):599-606. PubMed ID: 17681036
[TBL] [Abstract][Full Text] [Related]
22. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
23. New insights to the ubiquitin-proteasome pathway (UPP) mechanism during spermatogenesis.
Hou CC; Yang WX
Mol Biol Rep; 2013 Apr; 40(4):3213-30. PubMed ID: 23268313
[TBL] [Abstract][Full Text] [Related]
24. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials.
Nabavi SF; Atanasov AG; Khan H; Barreca D; Trombetta D; Testai L; Sureda A; Tejada S; Vacca RA; Pittalà V; Gulei D; Berindan-Neagoe I; Shirooie S; Nabavi SM
Cancer Lett; 2018 Oct; 434():101-113. PubMed ID: 30030139
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
26. DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry.
Okada M; Hozumi Y; Tanaka T; Suzuki Y; Yanagida M; Araki Y; Evangelisti C; Yagisawa H; Topham MK; Martelli AM; Goto K
Cell Signal; 2012 Aug; 24(8):1573-82. PubMed ID: 22516102
[TBL] [Abstract][Full Text] [Related]
27. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
Graham SH; Liu H
Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
[TBL] [Abstract][Full Text] [Related]
28. The role of ubiquitin-proteasome pathway in spermatogenesis.
Dong LH; Ran ML; Li Z; Peng FZ; Chen B
Yi Chuan; 2016 Sep; 38(9):791-800. PubMed ID: 27644740
[TBL] [Abstract][Full Text] [Related]
29. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
[TBL] [Abstract][Full Text] [Related]
30. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
[TBL] [Abstract][Full Text] [Related]
31. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
33. Ciliary neurotrophic factor upregulates ubiquitin-proteasome components in a rat model of neuronal injury.
Jho DH; Engelhard HH; Gandhi R; Chao J; Babcock T; Ong E; Espat NJ
Cytokine; 2004 Sep; 27(6):142-51. PubMed ID: 15304243
[TBL] [Abstract][Full Text] [Related]
34. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
[TBL] [Abstract][Full Text] [Related]
36. [Ubiquitin-proteasome pathway and virus infection].
Li ZF; Pang Y
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):151-6. PubMed ID: 15969100
[TBL] [Abstract][Full Text] [Related]
37. Multi-output Model with Box-Jenkins Operators of Quadratic Indices for Prediction of Malaria and Cancer Inhibitors Targeting Ubiquitin- Proteasome Pathway (UPP) Proteins.
Casañola-Martin GM; Le-Thi-Thu H; Pérez-Giménez F; Marrero-Ponce Y; Merino-Sanjuán M; Abad C; González-Díaz H
Curr Protein Pept Sci; 2016; 17(3):220-7. PubMed ID: 26427384
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
Tai HC; Schuman EM
Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
[TBL] [Abstract][Full Text] [Related]
39. [The role of parkin in Parkinson's disease].
Miklya I; Göltl P; Hafenscher F; Pencz N
Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-proteasome pathway mediates degradation of APH-1.
He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
